Amyotrophic lateral sclerosis: Thyroid and prolactin hormone changes in thyrotropin-releasing hormone therapy
โ Scribed by D. Testa; P. G. Chiodini; F. Girotti; R. Attanasio
- Publisher
- Springer Milan
- Year
- 1990
- Tongue
- English
- Weight
- 239 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1590-1874
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Amyotrophic lateral sclerosis (ALS) and its variants are feared progressive neurological diseases of which the etiology and pathogenesis are unknown and for which therapy is unavailable. In 1983, Engel and associates 1 11 reported that infusion of thyrotropin-releasing hormone (TRH) improved strengt
To investigate the exaggerated prolactin (PRL) responsiveness to thyrotropin-releasing hormone (TRH) in patients with benign breast disease (BBD), 18 patients and 13 healthy controls underwent an 8-week-long thyroid hormone treatment. The clinical effect of thyroid hormones on cyclical mastodynia an
Increased dopaminergic activity has been postulated to be one of the main causes of schizophrenia. To evaluate this hypothesis further, the interrelation between dopamine, prolactin, thyrotropin (TSH) and L-thyroxine was studied by determining their concentrations in the serum of ten acutely ill sch